Cargando…
Electronic Health Record-Based Genome-Wide Meta-Analysis Identifies New Susceptibility Loci for Non-Alcoholic Fatty Liver Disease
Background: Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of liver disease. Observational studies documented associations of NAFLD with several chronic and infectious diseases but whether these associations underlie causal effects is unknown. The molecular mechanisms and genet...
Autores principales: | Ghodsian, Nooshin, Abner, Erik, Gobeil, Émilie, Taba, Nele, Amand, Alexis St-, Perrot, Nicolas, Couture, Christian, Bossé, Yohan, Mitchell, Patricia, Vohl, Marie-Claude, Thériault, Sébastien, Tchernof, André, Esko, Tõnu, Mathieu, Patrick, Arsenault, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135512/ http://dx.doi.org/10.1210/jendso/bvab048.1024 |
Ejemplares similares
-
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Emilie, et al.
Publicado: (2021) -
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
por: Ghodsian, Nooshin, et al.
Publicado: (2021) -
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Émilie, et al.
Publicado: (2022) -
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases
por: Gagnon, Eloi, et al.
Publicado: (2022) -
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
por: Gagnon, Eloi, et al.
Publicado: (2023)